Publications by authors named "J E Marquez-Garcia"
Article Synopsis
- A study in Mexico aimed to determine the detection rate of circulating tumor cells (CTCs) in Mexican women with early breast cancer using specific biomarkers KRT19, MUC1, and SCGB2A2.
- The research involved 62 women, and blood samples were analyzed pre-surgery to quantify biomarker expression, confirming breast cancer in 59 cases.
- Results showed that 32.2% of cases expressed at least one biomarker, with MUC1 detection rates similar to other populations but lower rates for KRT19 and SCGB2A2, highlighting the need for standardized methods in CTC detection.
In- Versus Out-Fracture: A Novel Concept in Naso-Orbito-Ethmoid Injury.
Craniomaxillofac Trauma Reconstr
September 2024
Study Design: A retrospective study.
Objective: The Markowitz-Manson classification system categorizes nasoorbitoethmoid (NOE) fractures by severity of injury and remaining integrity of the medial canthal tendon. However, this system does not account for direction of bony displacement (in-fracture vs out-fracture), which can greatly affect symptomatology and management.
Background: The global inequity in the distribution of COVID-19 vaccines underscores the urgent need for innovative and cost-effective vaccine technologies to address access disparities and implement local manufacturing capabilities. This is essential for achieving and sustaining widespread immunity, and for ensuring timely protection of vulnerable populations during future booster campaigns in lower- middle income countries (LMICs).
Methods: To address this need, we conducted a phase II clinical trial to evaluate the safety and immunogenicity of the locally manufactured AVX/COVID-12 "Patria" (AVX) vaccine as a booster dose.
Background: Predictors for permanent nipple-areolar complex (NAC) insensitivity after reduction mammaplasty are sparsely defined.
Objectives: We analyzed factors associated with NAC insensitivity over long-term follow-up.
Methods: A retrospective analysis of reduction mammaplasties on 1598 breasts performed by 4 surgeons from March 2015 to February 2023 was conducted.
Background: Detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by naso/oropharyngeal swabbing may expose health-care workers to the virus and is technically challenging. The Salivette® is an alternative saliva-collection device with an oral cotton swab containing citric acid to stimulate saliva production, which may have an unpleasant taste. We present a pilot study comparing the Salivette® Cortisol (SC), which uses a synthetic swab without citric acid, against oropharyngeal swabbing for the detection of SARS-CoV-2 by reverse transcription quantitative polymerase chain reaction (RT-qPCR).
View Article and Find Full Text PDF